Medpace Holdings, Inc. (MEDP) financials

Medpace Holdings, Inc. (MEDP) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Medpace Holdings, Inc. reported revenue of $2.53B, up 20.0% year over year, net income of $451M, diluted EPS of $15.28 and free cash flow of $682M.

Revenue (fiscal 2025)

$2.53B

Revenue growth (fiscal 2025)

20.0%

Net income (fiscal 2025)

$451M

Diluted EPS (fiscal 2025)

$15.28

Free cash flow (fiscal 2025)

$682M

Medpace Holdings, Inc. files with the U.S. Securities and Exchange Commission under CIK 0001668397, classified as Services-Commercial Physical & Biological Research.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.